These two latter experiments (Supplementary Fig. 1) suggest that the increased tumor control observed in Suv39h1-defective mice (Fig. 1A–D) could be attributed, at least partially, to an increased anti-tumor activity of Suv39h1-KO CD8+ T cells. This evidence concerns the gene SUV39H1 and neoplasm.